Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check28 days agoChange DetectedThe web page has been updated to include a new clinical trial for a combination treatment involving pembrolizumab, letrozole, and palbociclib for postmenopausal patients with metastatic estrogen receptor positive breast cancer. Additionally, the page now includes a disclaimer about the U.S. government's non-review of all studies listed.SummaryDifference100%
- Check35 days agoChange DetectedThe webpage has removed detailed information about a clinical trial for a combination treatment of breast cancer, including specifics about the study's objectives, eligibility criteria, and treatment protocols. Additionally, there are new error messages indicating server issues.SummaryDifference100%
- Check43 days agoChange DetectedThe web page has been updated from version 2.16.5 to version 2.16.6.SummaryDifference0.0%
- Check50 days agoChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference0.6%
Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.